¼¼°è Ç×±Õ ¼ººÐ ½ÃÀå : Á¶»ç º¸°í¼ - »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)
Global Antimicrobial Ingredients Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
Ç×±Õ ¼ººÐ ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 66¾ï 9,000¸¸ ´Þ·¯¿¡¼ 2032³â 106¾ï 2,000¸¸ ´Þ·¯ ±Ùó ½ÃÀå ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç±â°£(2024³â-2032³â) µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.28%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù
Ç×±Õ ¼ººÐÀº ¹Ì»ý¹°, ƯÈ÷ ¹ÚÅ׸®¾Æ, Áø±Õ, ¹ÙÀÌ·¯½º ¹× ±âŸ º´¿øÃ¼ÀÇ Áõ½ÄÀ» ¾ïÁ¦Çϰųª ÆÄ±«Çϱâ À§ÇØ Á¦Ç°¿¡ ¹èÇյǴ ¹°ÁúÀ» ÀǹÌÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼ººÐÀº ÀÇ·á, ÆÛ½º³ÎÄɾî, ¼¶À¯ Á¦Ç°, ½ÄÀ½·á, °¡Á¤¿ëǰ µî ´Ù¾çÇÑ »ê¾÷¿¡¼ »ç¿ëµÇ¸ç À¯ÇØÇÑ ¹Ì»ý¹°ÀÇ Áõ½Ä¿¡ ´ëÇÑ º¸È£ÃþÀ» Á¦°øÇÕ´Ï´Ù.
½ÃÀå ¿ªÇÐ
Ç×±Õ ¼ººÐ ½ÃÀåÀº À§»ý, °¨¿° ¿¹¹æ, °Ç° ÁöÇâ Áõ°¡¸¦ ¹Ý¿µÇÏ´Â ´Ù¾çÇÑ ¿äÀÎÀÇ ¼ö·Å¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. ¼¼°è °Ç° °úÁ¦, ƯÈ÷ COVID-19 ÆÒµ¥¹Í¿¡ ¹Ð·Á Ç×±Õ ¼ººÐÀ» Æ÷ÇÔÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ ¼ö¿ä´Â ÀÇ·á, ÆÛ½º³ÎÄɾî, ¼ÒºñÀç, ¼¶À¯ Á¦Ç° µî ´Ù¾çÇÑ ºÐ¾ß¿¡ °ÉÃÄ ÀÖ½À´Ï´Ù. ÀÇ·á »ê¾÷Àº °¨¿° ¿¹¹æÀ» À§ÇØ ÀÇ·á±â±â¿Í Ç¥¸é¿¡ Ç×±Õ ¼Ö·ç¼ÇÀ» ã´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¼ÒºñÀç »ê¾÷Àº ¼±È£µµÀÇ º¯È¿¡ ÈûÀÔ¾î ºñ´©³ª °¡Á¤¿ë ¼¼Á¦ µîÀÇ Á¦Ç°¿¡ Ç×±Õ ¼ººÐÀ» ¹èÇÕÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ Áؼö, ±â¼ú Áøº¸, Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÇ Ãß±¸´Â Ç×±ÕÁ¦ ³»¼º¿¡ ´ëÇÑ ¿ì·Á¸¦ ´Ù·ç´Â °ÍÀÔ´Ï´Ù. Ç¥¸é¿ë Ç×±Õ ÄÚÆÃÁ¦, ȯ°æ Ä£ÈÀûÀÎ ¼ººÐ, ½Äǰ ¹× ½Äǰ »ê¾÷¿¡ÀÇ ÀÀ¿ëÀÌ ½ÃÀå ¼ºÀå¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. À§»ýÀǽÄÀÌ »Ñ¸®±í°í »ê¾÷°è°¡ ¾ÈÀü¼ºÀ» ¿ì¼±ÇÏ´Â °¡¿îµ¥ Ç×±Õ¼ººÐ ½ÃÀåÀº Áö¼ÓÀûÀÎ È®´ë¿Í ±â¼ú Çõ½ÅÀÌ Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.
Á¶»ç º¸°í¼´Â Æ÷ÅÍÀÇ Five Force ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ µµ±¸´Â Ç×±Õ ¼ººÐ ½ÃÀå¿¡¼ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Ç×±Õ ¼ººÐ »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±ÙÀ» Á¦°øÇÕ´Ï´Ù.
½ÃÀå ¼¼ºÐÈ
Ç×±Õ ¼ººÐ ½ÃÀå º¸°í¼ÀÇ ÀÌ ¼½¼Ç¿¡¼´Â ±¹°¡ ¹× Áö¿ª ¼öÁØÀÇ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇϹǷΠÀü·«°¡´Â ÇâÈÄ ±âȸ¿¡¼ °¢ Á¦Ç° ¹× ¼ºñ½ºÀÇ ´ë»ó °èÃþÀ» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.
Á¦Ç° À¯Çüº°
- Ç×±ÕÁ¦
- Ç×Áø±ÕÁ¦
- Ç×¹ÙÀÌ·¯½ºÁ¦
- Ç×±â»ýÃæÁ¦
Çüź°
¿ëµµº°
- ½ºÅ²Äɾî Á¦Ç°
- Çì¾î Äɾî Á¦Ç°
- °æ±¸ Äɾî Á¦Ç°
- ¸ÞÀÌÅ©¾÷ Á¦Ç°
- ±âŸ
Áö¿ª ºÐ¼®
ÀÌ ¼½¼Ç¿¡¼´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼ Ç×±Õ ¼ººÐ ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑÀÌ º¸°í¼´Â ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÁßÁ¡À» µÓ´Ï´Ù.
¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖ´Â °æ¿ì Google¿¡ ¹®ÀÇÇϼ¼¿ä. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼¹®
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
- ½ÃÀå ÇöȲ
Á¦3Àå Ç×±Õ ¼ººÐ-»ê¾÷ ºÐ¼®
- ¼Ò°³: ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ½ÃÀå ±âȸ
- ¾÷°è µ¿Çâ
- Porter's Five Forces ºÐ¼®
- ½ÃÀå ¸Å·Âµµ ºÐ¼®
Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®
- ¹ë·ùüÀÎ ºÐ¼®
- ¿øÀç·á ºÐ¼®
- ¿øÀç·á ¸®½ºÆ®
- ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
- ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
- ÀáÀçÀû ±¸¸ÅÀÚ ¸ñ·Ï
- ¸¶ÄÉÆÃ Ã¤³Î
- Á÷Á¢ ¸¶ÄÉÆÃ
- °£Á¢ ¸¶ÄÉÆÃ
- ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ
Á¦5Àå Ç×±Õ Àç·á ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°
- Á¦Ç° À¯Çüº° °³¿ä
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- Á¦Ç° À¯Çüº° ºÐ¼®
- Ç×±ÕÁ¦
- Ç×Áø±ÕÁ¦
- Ç×¹ÙÀÌ·¯½ºÁ¦
- Ç×±â»ýÃæÁ¦
Á¦6Àå Ç×±Õ ¼ººÐ ½ÃÀå ºÐ¼® : Çüź°
- Çüź° °³¿ä
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- Çüź° ºÐ¼®
- °ÇÁ¶
- ¾×ü
Á¦7Àå Ç×±Õ ¼ººÐ ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°
- ÃÖÁ¾ ¿ëµµº° °³¿ä
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- ÃÖÁ¾ ¿ëµµº° ºÐ¼®
- ½ºÅ²Äɾî Á¦Ç°
- Çì¾î Äɾî Á¦Ç°
- °æ±¸ Äɾî Á¦Ç°
- ¸ÞÀÌÅ©¾÷ Á¦Ç°
- ±âŸ
Á¦8Àå Ç×±Õ ¼ººÐ ½ÃÀå ºÐ¼® : Áö¿ªº°
- Áö¿ªº° Àü¸Á
- ¼Ò°³
- ºÏ¹Ì ¸ÅÃ⠺м®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ºÏ¹Ì : ºÎ¹®º°
- ºÏ¹Ì : ±¹°¡º°
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- À¯·´ ¸ÅÃ⠺м®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- À¯·´ : ºÎ¹®º°
- À¯·´: ±¹°¡º°
- ¿µ±¹
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
- ¾Æ½Ã¾ÆÅÂÆò¾ç: ±¹°¡º°
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- È£ÁÖ
- µ¿³²¾Æ½Ã¾Æ
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
- ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- Æä·ç
- Ä¥·¹
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«: ±¹°¡º°
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- À̽º¶ó¿¤
- ³²¾ÆÇÁ¸®Ä«
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦9Àå Ç×±Õ ¼ººÐ ±â¾÷°æÀï ±¸µµ
- Ç×±Õ¼ººÐ ½ÃÀåÀÇ °æÀï
- ÆÄÆ®³Ê½Ê/Á¦ÈÞ/ÇùÁ¤
- ÇÕº´,Àμö
- ½ÅÁ¦Ç° ¹ß¸Å
- ±âŸ °³¹ß
Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ
- ±â¾÷ Á¡À¯À² ºÐ¼®
- ½ÃÀå ÁýÁßµµ
- Ashland Global Holdings Inc.
- BASF SE
- Croda International Plc.
- Lonza Group Ltd.
- Clariant AG
- Dow
- Solvay SA
- Akzo Nobel NV
- Wacker Chemie AG
- Evonik Industries AG
BJH
The global demand for Antimicrobial Ingredients Market is presumed to reach the market size of nearly USD 10.62 Billion by 2032 from USD 6.69 Billion in 2023 with a CAGR of 5.28% under the study period 2024 - 2032.
Antimicrobial ingredients refer to substances that are incorporated into products to inhibit or destroy the growth of microorganisms, particularly bacteria, fungi, viruses, or other pathogens. These ingredients are used in various industries, including healthcare, personal care, textiles, food and beverage, and household products, to provide a layer of protection against the proliferation of harmful microbes.
MARKET DYNAMICS
The Antimicrobial ingredients market is driven by a convergence of factors reflecting the heightened emphasis on hygiene, infection prevention, and health consciousness. Fueled by global health challenges, especially the COVID-19 pandemic, there is an increased demand for products incorporating antimicrobial ingredients. This demand spans diverse sectors, including healthcare, personal care, consumer goods, and textiles. The healthcare sector plays a pivotal role in seeking antimicrobial solutions for medical devices and surfaces to prevent infections. The consumer goods industry, driven by changing preferences, integrates antimicrobial ingredients into products such as soaps and household cleaners. Regulatory compliance, advancements in technology, and the pursuit of innovative solutions address concerns about antimicrobial resistance. Antimicrobial coatings for surfaces, environmentally friendly ingredients, and applications in the food and beverage industry further contribute to market growth. As hygiene awareness persists and industries prioritize safety, the antimicrobial ingredients market is poised for sustained expansion and innovation.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of antimicrobial ingredients. The growth and trends of antimicrobial ingredients industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the antimicrobial ingredients market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Antibacterial Agents
- Antifungal Agents
- Antiviral Agents
- Antiparasitic Agents
By Form
By End-Use
- Skin Care Products
- Hair Care Products
- Oral Care Products
- Make-Up Products
- Others
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Antimicrobial Ingredients market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Antimicrobial Ingredients market include Ashland Global Holdings Inc., BASF SE, Croda International Plc., Lonza Group Ltd., Clariant AG, Dow, Solvay SA, Akzo Nobel N.V., Wacker Chemie AG, Evonik Industries AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . ANTIMICROBIAL INGREDIENTS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Form
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL ANTIMICROBIAL INGREDIENTS MARKET ANALYSIS BY PRODUCT TYPE
- 5.1 Overview by Product Type
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Product Type
- 5.4 Antibacterial Agents Historic and Forecast Sales by Regions
- 5.5 Antifungal Agents Historic and Forecast Sales by Regions
- 5.6 Antiviral Agents Historic and Forecast Sales by Regions
- 5.7 Antiparasitic Agents Historic and Forecast Sales by Regions
6 . GLOBAL ANTIMICROBIAL INGREDIENTS MARKET ANALYSIS BY FORM
- 6.1 Overview by Form
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Form
- 6.4 Dry Historic and Forecast Sales by Regions
- 6.5 Liquid Historic and Forecast Sales by Regions
7 . GLOBAL ANTIMICROBIAL INGREDIENTS MARKET ANALYSIS BY END-USE
- 7.1 Overview by End-use
- 7.2 Historical and Forecast Data
- 7.3 Analysis by End-use
- 7.4 Skin Care Products Historic and Forecast Sales by Regions
- 7.5 Hair Care Products Historic and Forecast Sales by Regions
- 7.6 Oral Care Products Historic and Forecast Sales by Regions
- 7.7 Make-up Products Historic and Forecast Sales by Regions
- 7.8 Others Historic and Forecast Sales by Regions
8 . GLOBAL ANTIMICROBIAL INGREDIENTS MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE ANTIMICROBIAL INGREDIENTS COMPANIES
- 9.1. Antimicrobial Ingredients Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF ANTIMICROBIAL INGREDIENTS INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Ashland Global Holdings Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. BASF SE
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Croda International Plc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Lonza Group Ltd.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Clariant AG
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Dow
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. Solvay SA
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Akzo Nobel N.V.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. Wacker Chemie AG
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. Evonik Industries AG
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies